Skip to content
SentinelMarket desk
Switch to dark mode

티움바이오

321550KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

4,080KRWMarket close of 10/22 (Thu)

Down -3.20%-135KRWMarket close of 10/22 (Thu)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/23 (Fri)4,080KRWFlat 0.00%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
4,165
High
4,265
Low
4,030
Day range
Day range low 4,030 high 4,265, open 4,165, close 4,080, previous close 4,215
Volume
7×10K shares
292.72 million KRW 0.74× the 20-session average

Market close of 10/22 (Thu)

Where it sits in the 1-year range

1-year close range 3,680 to 13,140 won, 4% up from the low

4% of the way up from the lowest close in 1 year (252 sessions) · -68.9% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-15.3B KRWOperating income over the last four quarters -15.3B KRW (loss)Operating income, 8 quarters
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move-3.20%usual range
  • Trading value0.7×usual range
  • Data date10/22 (Thu)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue3.0B KRWRevenue bars for the last 5 quarters; the dark bar is this quarter
    vs. year ago
    +40.1%
    vs. prior quarter
    -33.7%
  • Operating income-4.5B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Still a loss
    vs. prior quarter
    Still a loss
  • Operating margin-153.8%Operating margin bars for the last 5 quarters; the dark bar is this quarter
    vs. year ago
    +100.0 pp
    vs. prior quarter
    -91.2 pp

Quarterly operating income trend

As of the latest official close · 2026-10-22Valuation filing date · 2026-05-15
2021Q1 -4.0B KRW2026Q1 -4.5B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 바이오 R&D

Down -3.11%

· 2 of 64 stocks up, preferred shares excluded · trading value 160.7B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -8.9%Down -3.75%41.7B KRW
디앤디파마텍Close over the last 20 sessions -9.3%Down -5.08%17.1B KRW
올릭스Close over the last 20 sessions -5.4%Down -1.22%13.7B KRW
SK바이오팜Close over the last 20 sessions -3.6%Down -0.13%12.8B KRW
알지노믹스Close over the last 20 sessions -8.9%Down -1.59%9.9B KRW

Schedule

  • Next data 10/26 (Mon) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 76% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.